Skip to main content
SpringerLink
Log in

Meningiomas: Role of Semaphorin3A Protein in Antiangiogenesis

  • Chapter
  • First Online:
Tumors of the Central Nervous System, Volume 7

Part of the book series: Tumors of the Central Nervous System ((TCNS,volume 7))

  • 1129 Accesses

Abstract

Meningiomas represent frequent tumors mainly characterized by a benign histology and an indolent clinical course. The histological grade and extent of surgical resection are considered to be the most powerful prognosticators for these neoplasias. Nonetheless, a percentage of meningiomas do display relapses despite a total macroscopic resection, although the reasons of this phenomenon still remain to be fully clarified. Herein the prognostic value of angiogenesis and of the expression of its regulators in completely surgically resected meningiomas is discussed. In particular, the role of semaphorin3A (SEMA3A) in the regulation of angiogenesis and the correlation between its expression and the risk of recurrence of meningiomas are illustrated.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Barresi V, Tuccari G (2010) Increased ratio of vascular endothelial growth factor to semaphorin3A is a negative prognostic factor in human meningiomas. Neuropathology 30(5):537–546

    Google Scholar 

  • Barresi V, Cerasoli S, Vitarelli E, Tuccari G (2007) Density of microvessels positive for CD105 (endoglin) is related to prognosis in meningiomas. Acta Neuropathol 114:147–156

    Article  PubMed  CAS  Google Scholar 

  • Barresi V, Cerasoli S, Tuccari G (2008) Correlative evidence that tumor cell-derived caveolin-1 mediates angiogenesis in meningiomas. Neuropathology 28:472–478

    Article  PubMed  Google Scholar 

  • Barresi V, Vitarelli E, Cerasoli S (2009) Semaphorin3A immunohistochemical expression in human meningiomas: correlation with the microvessel density. Virchows Arch 454:563–571

    Article  PubMed  CAS  Google Scholar 

  • Catalano A, Caprai P, Rodilossi S, Betta P, Castellucci M, Casazza A, Tamagnone L, Procopio A (2004) Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J 18:358–360

    PubMed  CAS  Google Scholar 

  • Christov C, Lechapt-Zalcman E, Adle-Biassette H, Nachev S, Gherardi RK (1999) Vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptor flt-1 in microcystic meningiomas. Acta Neuropathol 98:414–420

    Article  PubMed  CAS  Google Scholar 

  • Ding S, Li C, Lin S, Liu D, Han Y, Zhang Y, Li L, Zhou L, Kumar S (2006) Comparative evaluation of microvessel density determined by CD34 or CD105 in benign and malignant gastric lesions. Hum Pathol 37:861–866

    Article  PubMed  CAS  Google Scholar 

  • Ferrara N, Davis-Smyth T (1997) The biology of vascular endothelial growth factor. Endocr Rev 18:4–25

    Article  PubMed  CAS  Google Scholar 

  • Folkman J (1995) Clinical applications of angiogenic research. N Engl J Med 333:1757–1763

    Article  PubMed  CAS  Google Scholar 

  • Folkman J, Shing Y (1992) Angiogenesis. J Biol Chem 267:10931–10934

    PubMed  CAS  Google Scholar 

  • Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G (2007) Semaphorin-3A and semaphoring-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem 282:26294–26305

    Article  PubMed  CAS  Google Scholar 

  • Kamitani H, Masuzawa H, Kanazawa I, Kubo T (2001) Recurrence of convexity meningiomas: tumour cells in the arachnoid membrane. Surg Neurol 56:228–235

    Article  PubMed  CAS  Google Scholar 

  • Kinjo T, al-Mefty O, Kanaan I (1993) Grade zero removal of supratentorial convexity meningiomas. Neurosurgery 33:394–399

    Article  PubMed  CAS  Google Scholar 

  • Luo Y, Raible D, Raper JA (1993) Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell 75:217–227

    Article  PubMed  CAS  Google Scholar 

  • Maiuri F, De Caro M, Esposito F, Cappabianca P, Strazzullo V, Pettinato G, de Divitiis E (2007) Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors. J Neurooncol 82:63–68

    Article  PubMed  Google Scholar 

  • Masood R, Cai J, Zheng T, Smith DL, Hinton DR, Gill PS (2001) Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors. Blood 98:1904–1913

    Article  PubMed  CAS  Google Scholar 

  • Miao HQ, Soker S, Feiner L, Alonso JL, Raper JA, Klagsbrun M (1999) Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol 12:233–242

    Google Scholar 

  • Narazaki M, Tosato G (2006) Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood 107:3892–3901

    Article  PubMed  CAS  Google Scholar 

  • Nishikawa R, Cheng SY, Nagashima R, Huang HJ, Cavenee WK, Matsutani M (1998) Expression of vascular endothelial growth factor in human brain tumors. Acta Neuropathol 96:453–462

    Article  PubMed  CAS  Google Scholar 

  • Osada R, Horiuchi A, Kikuchi N, Ohira S, Ota M, Katsuyama Y, Konishi I (2006) Expression of semaphorins, vascular endothelial growth factor and their common receptor neuropilins and allelic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum Pathol 37:1414–1425

    Article  PubMed  CAS  Google Scholar 

  • Perry A, Stafford SL, Scheithauer BW, Lohse CM, Wollan PC (1999) “Malignancy” in meningiomas: a clinico-pathological study of 116 patients with grading implications. Cancer 85:2046–2056

    PubMed  CAS  Google Scholar 

  • Perry A, Louis DN, Scheithauer BW, Budka H, von Deimling A (2007) Meningiomas. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds) WHO classification of tumors of the central nervous system. IARCC Press, Lyon

    Google Scholar 

  • Pietsch T, Valter MM, Wolf HK (1997) Expression and distribution of vascular endothelial growth factor protein in human brain tumors. Acta Neuropathol 93:109–117

    Article  PubMed  CAS  Google Scholar 

  • Pistolesi S, Boldrini L, Gisfredi S, De Ieso K, Casacci T, Caniglia M, Lupi G, Leocata P, Basolo F, Pingitore R, Parenti G, Fontanini G (2004) Angiogenesis in intracranial meningiomas: immunohistochemical and molecular study. Neuropathol Appl Neurobiol 30:118–125

    Article  PubMed  CAS  Google Scholar 

  • Rieger J, Wick W, Weller M (2003) Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia 42:379–389

    Article  PubMed  Google Scholar 

  • Saad RS, El-Gohary Y, Memari E, Liu YL, Silverman JF (2005) Endoglin (CD105) and vascular endothelial growth factor as prognostic markers in esophageal adenocarcinoma. Hum Pathol 36:955–961

    Article  PubMed  CAS  Google Scholar 

  • Simpson D (1957) The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 20:22–39

    Article  PubMed  CAS  Google Scholar 

  • Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M (1998) Neuropilin-1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 92:735–745

    Article  PubMed  CAS  Google Scholar 

  • Soker S, Miao HQ, Nomi M, Takashima S, Klagsbrun M (2002) VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165 receptor binding. J Biol Chem 85:357–368

    CAS  Google Scholar 

  • Vacca A, Scavelli C, Serini G, Di Pietro G, Citrulli T, Merchionne F, Ribatti D, Bussolino F, Guidolin D, Piaggio G, Bacigalupo A, Dammacco F (2006) Loss of inhibitory semaphorin3A (sema3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma. Blood 108:1661–1667

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Patologia Umana, Policlinico Universitario G. Martino, Pad D, Via Consolare Valeria, 98125, Messina, Italy

    Valeria Barresi

Authors
  1. Valeria Barresi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Valeria Barresi .

Editor information

Editors and Affiliations

  1. , Kean University, Room 213, Library building, Morris Avenue 1000, Union, 07083, New Jersey, USA

    M.A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

Barresi, V. (2012). Meningiomas: Role of Semaphorin3A Protein in Antiangiogenesis. In: Hayat, M. (eds) Tumors of the Central Nervous System, Volume 7. Tumors of the Central Nervous System, vol 7. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-2894-3_1

Download citation

  • DOI: https://doi.org/10.1007/978-94-007-2894-3_1

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-007-2893-6

  • Online ISBN: 978-94-007-2894-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation